Back to search

Article

Inhibition of formyl peptide receptors improves the outcome in a mouse model of Alzheimer disease

2020-03-30

Abstract excerpt

<title>Abstract</title> <p>Background: An important hallmark of Alzheimer's disease (AD) is the increase of Aβ1-42 burden and its accumulation to senile plaques, leading the reactive gliosis and neurodegeneration. The modulation of glia cell function represent an attractive therapeutic strategy, but is currently limited by an incomplete understanding of its relevance for AD. The chemotactic G-protein coupled form...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
79b6ab34-3b84-5f50-92d8-a66930560cfc
DOI
10.21203/rs.2.17967/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Inhibition of formyl peptide receptors improves the outcome in a mouse model of Alzheimer diseaseDOI 10.21203/rs.2.17967/v2
Amyloid beta and its naturally occurring N-terminal variants are potent activators of human and mouse formyl peptide receptor 1Semantic proximity
The formyl peptide receptor 2 regulates microglial phenotype through immunometabolism : implications for Alzheimer's diseaseSemantic proximity
C5aR1 antagonism suppresses inflammatory glial gene expression and alters cellular signaling in an aggressive Alzheimer’s modelSemantic proximity
Reversal of β-amyloid induced microglial toxicity <i>in vitro</i> by activation of Fpr2/3Semantic proximity
C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimer’s diseaseSemantic proximity
Conditional genetic deletion of CSF1 receptor in microglia ameliorates the physiopathology of Alzheimer’s diseaseSemantic proximity
Conditional Genetic Deletion of CSF1&nbsp;Receptor in Microglia Ameliorates the Physiopathology of Alzheimer’s DiseaseSemantic proximity
Carprofen alleviates Alzheimer-like phenotypes of 5XFAD transgenic mice by targeting the pathological hallmarks induced by amyloid-β aggregationSemantic proximity
The TREM2 targeting small molecule Sob-AM2 improves cognition independent of Aβ plaque alteration in 5xFAD miceSemantic proximity
Ex vivo Expanded Human Regulatory T Cells Modify Neuroinflammation in a Preclinical Model of Alzheimer’s diseaseSemantic proximity
Small molecule p75NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration, and cognitive deficits in AβPP(L/S) transgenic mice.Semantic proximity
5xFAD-NSG mice: a preclinical Alzheimer model for human cell therapy studiesSemantic proximity
Select a neighboring publication to make it the new centre.